Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2010, Article ID 978710, 11 pages
http://dx.doi.org/10.1155/2010/978710
Research Article

The Antioxidant Effect of Erythropoietin on Thalassemic Blood Cells

Department of Hematology, Hadassah-Hebrew University Medical Center, Ein-Kerem, 91120 Jerusalem, Israel

Received 25 August 2010; Accepted 14 November 2010

Academic Editor: Aurelio Maggio

Copyright © 2010 Johnny Amer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Mohsen S. Elalfy, Amira A. M. Adly, Eman A. Ismail, Yasmine I. Elhenawy, and Islam R. Elghamry, “Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients,” European Journal of Haematology, 2013. View at Publisher · View at Google Scholar
  • Samir Awadallah, “Protein Antioxidants in Thalassemia,” vol. 60, pp. 85–128, 2013. View at Publisher · View at Google Scholar
  • Li Wang, Lijun Di, and Constance Tom Noguchi, “AMPK is Involved in Mediation of Erythropoietin Influence on Metabolic Activity and Reactive Oxygen Species Production in White Adipocytes,” The International Journal of Biochemistry & Cell Biology, 2014. View at Publisher · View at Google Scholar
  • Eitan Fibach, and Eliezer A. Rachmilewitz, “Does Erythropoietin Have a Role in the Treatment of β-Hemoglobinopathies?,” Hematology/Oncology Clinics of North America, 2014. View at Publisher · View at Google Scholar
  • Zuzana Zidova, Katarina Kapralova, Pavla Koralkova, Renata Mojzikova, Vladimir Divoky, Monika Horvathova, and Dalibor Dolezal, “DMT1-Mutant Erythrocytes have Shortened Life Span, Accelerated Glycolysis and Increased Oxidative Stress,” Cellular Physiology And Biochemistry, vol. 34, no. 6, pp. 2221–2231, 2014. View at Publisher · View at Google Scholar
  • Li Wang, Lijun Di, and Constance Tom Noguchi, “Erythropoietin, a Novel Versatile Player Regulating Energy Metabolism beyond the Erythroid System,” International Journal of Biological Sciences, vol. 10, no. 8, pp. 921–939, 2014. View at Publisher · View at Google Scholar
  • Eitan Fibach, and Mutaz Dana, “Oxidative stress in Paroxysmal Nocturnal Hemoglobinuria and other conditions of complement-mediated hemolysis,” Free Radical Biology and Medicine, 2015. View at Publisher · View at Google Scholar
  • Gradinaru, Margina, Ilie, Borsa, Ionescu, and Prada, “Correlation between erythropoietin serum levels and erythrocyte susceptibility to lipid peroxidation in elderly with type 2 diabetes,” Acta Physiologica Hungarica, vol. 102, no. 4, pp. 400–408, 2015. View at Publisher · View at Google Scholar
  • Leigh Sundem, Kuang-Ching Chris Tseng, Haiyan Li, John Ketz, Mark Noble, and John Elfar, “Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects,” The Journal of Hand Surgery, 2016. View at Publisher · View at Google Scholar
  • Seyed Noureddin Nematollahi-mahani, Tunku Kamarul, Mohammad Reza Zarrindast, Ali Mohammad Sharifi, Fatemeh Nouri, and Parvin Salehinejad, “Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton’s Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study,” Cellular and Molecular Neurobiology, vol. 36, no. 5, pp. 689–700, 2016. View at Publisher · View at Google Scholar
  • Hara T. Georgatzakou, Marianna H. Antonelou, Issidora S. Papassideri, and Anastasios G. Kriebardis, “Red blood cell abnormalities and the pathogenesis of anemia in end-stage renal disease,” PROTEOMICS - Clinical Applications, vol. 10, no. 8, pp. 778–790, 2016. View at Publisher · View at Google Scholar
  • Hara T. Georgatzakou, Vassilis L. Tzounakas, Anastasios G. Kriebardis, Athanassios D. Velentzas, Effie G. Papageorgiou, Artemis I. Voulgaridou, Apostolos C. Kokkalis, Marianna H. Antonelou, and Issidora S. Papassideri, “Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy,” European Journal of Haematology, 2017. View at Publisher · View at Google Scholar
  • Amira A. Adly, and Eman A. Ismail, “Management of Children With β-Thalassemia Intermedia,” Journal of Pediatric Hematology/Oncology, vol. 40, no. 4, pp. 253–268, 2018. View at Publisher · View at Google Scholar